THE INVESTORS COLISEUM WELCOMES PRINCE ALBERT, SASKATCHEWAN'S NUVOPHARMS INC. TO ITS WEBSITE. “Driven by Passion, Backed by Science.”

Press Release

Toronto, Ontario, Canada – December 1st, 2020 - The Investors Coliseum (IC), a subsidiary of Pinnacle Capital Markets LTD. ("the Company”), is pleased to announce that medical cannabis producer NuvoPharms Inc. has become the latest company to retain the services of www.theinvestorscoliseum.com. NuvoPharms Inc. is a fresh, unique, cutting-edge company that the Coliseum is thrilled to be actively showcasing. The Investors Coliseum and NuvoPharms CEO Mr. Jamie Novotny have worked diligently to provide a vast array of material to showcase NuvoPharms. Please visit the website for a more in-depth look:

https://theinvestorscoliseum.com/featured-companies/nuvopharms-inc

About NuvoPharms Inc.
NuvoPharms is a medical cannabis business that is based in Prince Albert, Saskatchewan. The company will focus on cultivating, processing, and selling medical cannabis. NuvoPharms will sell affordable, high quality, organic-grown medical cannabis to registered patients, wholesalers, and retailers. The company will be owned by a group of equity shareholders, including Jamie Novotny, owner of NuvoMedic Canna Consulting, a medical cannabis consulting firm in Prince Albert. NuvoPharms’ products will be distributed through NuvoMedic, the NuvoPharms online store, and through retailers and distributors. The company will look to gain market share in the provincial, national, and international markets.

Jamie Novotny Chief Executive Officer of NuvoPharms Inc. Commented:
"We have retained the services of the Investor's Coliseum to facilitate the extension of our reach into all areas of the Capital Markets. We understand the importance of sharing our unique profile and story widely and are extremely excited to be working closely with the www.theinvestorscoliseum.com Coliseum team."

NuvoPharms Inc. prides itself on being 100% science driven. “We are continually analyzing the most relevant and current cannabis research under the guidance of our Chief Medical Officer and Physician Head of Cultivation. This allows us to not only produce high quality products, but to mindfully tailor production to ensure that the end result is truly effective medicinal cannabis that is better suited to treat and manage a wide spectrum of medical conditions.” - Jamie Novotny

Mr. Spyros P. Karellas, CEO and CO-Founder stated
"I am extremely pleased with the participation of NuvoPharms Inc. to the website. Jamie and his entire group have done years of analysis on the benefits of cannabis and we look forward to showcasing NuvoPharms to our interested subscribers and the public at large. Our goal at The Investors Coliseum is and will always be to focus on companies on the site that are superior in quality and that our subscribers and followers want to hear and learn about.

The Company's website, https://theinvestorscoliseum.com please visit us and subscribe!!

Contact:
Spyros P. Karellas
CEO & Co-Founder
www.theinvestorscoliseum.com
spyros@theinvestorscoliseum.com

Chris Waldron
COO & CO-Founder
www.theinvestorscoliseum.com
chris@theinvestorscoliseum.com

Pinnacle Capital Markets LTD., its subsidiary Investors Coliseum and the website theInvestorscoliseum.com, (together, “Investors Coliseum”) is an online investor community that connects active investors and small-cap public and private companies in various markets and industry sectors. Investors Coliseum is not registered as a broker, dealer, exempt market dealer, or any other registrant in any securities regulatory jurisdiction and will not be performing any registerable activity as defined by the applicable regulatory or securities bodies in any jurisdiction. Investors Coliseum has in no way passed upon the merits of any of the featured companies or current deals and has not reviewed the content of any disclosure provided by such companies for adequacy or accuracy.

82 Richmond Street east
Toronto, Ontario Canada
M5C 1P1

With over 30 plus years of experience in the Canadian Capital Markets and Investor Relations arena, we understand that (now more than ever) the accurate and timely dissemination of information is critical to the investing public. It is from this notion the Coliseum was born. The Investors Coliseum is a dynamic new way for investors to acquire accurate and timely information on our featured public and private companies and their related industries and sectors. By bringing new exciting equity opportunities and companies into the Coliseum, our goal is to provide a top-level of communication between themselves and the investing public.

This release was published on openPR.